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Background: The aim of the present work was to evaluate the antibacterial effect of 3,4-DHPEA-EA
(methyl-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-formyl-2-methyl-3,4-dihydro-2H-pyran-5-carboxylate), a
derivate of oleuropein, against a range of Gram-positive bacteria, including ATCC strains, food and clinical isolates.
Methods: The minimum inhibitory concentrations (MICs) of 3,4-DHPEA-EA were determined by the broth
microdilution method and the Bioscreen C.
Results: 3,4-DHPEA-EA was effective against ATCC and clinical isolates of Staphylococcus aureus (MIC values between
125 and 250 μg/ml) and ATCC and clinical isolates of Staphylococcus epidermidis (MIC values between 7.81 and
62.5 μg/ml). No significant differences were observed between the two solvents (methanol and DMSO) used to
dissolve 3,4-DHPEA-EA.
Conclusions: The results obtained could be used to develop novel therapies for the treatment of skin infections.
Further studies need to be performed to elucidate the formation of 3,4-DHPEA-EA by acid hydrolysis of
oleuropein in the human stomach.
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The potential beneficial effects of biophenols from olives
(Olea europaea L.) has been observed in several studies,
with antioxidant, anti-inflammatory and antimicrobial
activities attributed to olive oil [1-3]. Although the
health effects of olive oil were traditionally attributed to
oleic acid, more recent knowledge has shown that the
phenolic fraction plays a crucial role in the reported bene-
fits [4]. Polyphenols that reach the large bowel can benefi-
cially modulate the gut microbial ecosystem increasing the
number of Bifidobacterium spp., Lactobacillus spp. and
Enterococcus spp. which are known for their anti-
inflammatory, immunoregulatory and cholesterol lower-
ing properties through production of short chain fatty
acids [5,6]. The most biologically relevant compounds* Correspondence: gmandalari@unime.it
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unless otherwise stated.contributing to the sensory and nutritional aspects of olives
and olive oil are oleuropein, hydroxytyrosol, quercetin,
ferulic acid, caffeic acid, p-hydroxybenzoic acid, protocate-
chuic acid, 3,4-dyhydroxyphenylacetic acid (3,4-DHPA),
homovanillic acid and vanilethanediol, whose metabolic
and transcriptional profiling has been recently evaluated
during fruit development [7]. Oleuropein, present in large
quantities in olive tree leaves and in low amounts in extra-
virgin olive oil, is known to be responsible for the bitter
taste of the oil. We have previously demonstrated that
complexes of olive biophenols with β-cyclodextrin were ef-
fective decreasing the oil bitterness and preserving from
decomposition during storage [8]. The acid-hydrolysis of
oleuropein in the stomach generates the formation of
a number of metabolites whose distribution and con-
centration is dependent on the acidity of the gastric
compartment [9]. The dyaldehydes originated by the
cleavage of the β-glycosidic bond are unstable in the lipid/
water interface and are converted into the metaboliteral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(3,4-DHPEA-EA) [10].
We have previously demonstrated that aliphatic alde-
hydes from Olea europeaea L. were active against hu-
man intestinal and respiratory tract infection strains,
whereas Mycoplasma spp. were sensitive to oleuropein
[11,12]. Other studies have also reported an antibacterial
and antifungal action of both olive leaves and olive
glutaraldehyde-like compounds [13,14]. A range of mi-
crobial gastrointestinal pathogens, including Escherichia
coli and Helicobacter pylori, and viruses such as para-
influenza type 3 virus were sensitive to olive oil phenolic
compounds [15-17].
The aim of the present work was to investigate the ef-
fectiveness of 3,4-DHPEA-EA against a range of Gram-






carboxylate) was obtained by enzymatic hydrolysis of
oleuropein, as a molecular evolution consequence of the
hemiacetal functionality of the aglycon 2, formed by glyco-
sidic bond cleavage (Figure 1). The lipidic/water interface
promotes the rapid rearrangement of the intermediate
oleuropeinenol 3 into the final stable biomolecule, the
transposed secoiridoid 4, within 5 min [18].
Thus, to a solution of 100 mg of oleuropein, previously
extracted from olive leaves, endogenous β-glucosidase
was added at 40°C for 6 h in 20 ml of a H2O/CHCl3 1:1
mixture, The mixture was evaporated and purified using
Waters XTerra C18 column on a Varian HPLC system




obtained as a yellow oil (20% yield). 1H and 13C NMR spec-
tra were in agreement with literature data [10].
Microbial strains and culture conditions
The following Gram-positive strains were used for the anti-
microbial testing and were obtained from the University
of Messina’s in-house culture collection (Messina, Italy):Figure 1 Synthesis of 3,4-DHPEA-EA from oleuropein.Staphylococcus aureus ATCC 51153, Staphylococcus aureus
ATCC 6538P, Staphylococcus aureus ATCC 43300,
Staphylococcus epidermidis ATCC 49134, Staphylo-
coccus epidermidis ATCC 35984, Staphylococcus epi-
dermidis ATCC 12228, Streptococcus pneumoniae ATCC
6003, Streptococcus pyogenes ATCC 19615, Streptococcus
pyogenes ATCC 10782, Listeria monocytogenes ATCC
7644, Listeria monocytogenes ATCC 1392, Enterococcus
hirae ATCC 10541, Moraxella catarrhalis ATCC 8176, 10
food isolates of L. monocytogenes belonging to serotypes
1/2a (7 strains) and 1/2b (3 strains), 14 clinical isolates
of S. aureus obtained from specimens of skin infections
and surgical infections, 13 clinical isolates of S. pneu-
moniae obtained from hospitalized patients, 14 clinical
isolates of S. pyogenes obtained from hospitalized patients,
16 clinical isolates of M. catarrhalis obtained from ocular
and respiratory tract infections, 13 clinical isolates from
S. epidermidis obtained from orthopedic protesis, 13 iso-
lates of E. fecium and 15 isolates from E. faecalis from
urinary tract infections.
Cultures for antimicrobial activity tests were grown ei-
ther in Mueller Hinton Broth (MHB, Oxoid, CM0405,
S. aureus, S. epidermidis, L. monocytogenes, E. hirae,
E. fecium, E. faecalis) or Brain Heart Infusion (BHI,
Difco) at 37°C (24 h). For solid media 1.5% (w/v) agar
(Difco) was added.
Antimicrobial testing
The minimum inhibitory concentrations (MICs) of 3,4-
DHPEA-EA solubilized in either methanol or dimethyl sulf-
oxide (DMSO) were determined by the broth microdilution
method, according to CLSI [19]. The MICs were also per-
formed in the Bioscreen C (Labsystems Oy, Helsinki,
Finland) for all strains as previously reported [20].
All experiments were performed in triplicate on three
independent days. A number of positive and negative con-
trols with selected antibiotics (ampicillin and ciprofloxacin)




The MIC values of 3,4-DHPEA-EA against the ATCC
strains tested are shown in Table 1. Results of negative
controls indicated the complete absence of inhibition of
Table 1 Minimum inhibitory concentration (MIC) of
3,4-DHPEA-EA against ATCC Gram-positive bacteria
Strain 3,4-DHPEA-EA
S. aureus ATCC 51153 125
S. aureus ATCC 6538P 125
S. aureus ATCC 43300 250
S. epidermidis ATCC 49134 7.81
S. epidermidis ATCC 35984 62.5
S. epidermidis ATCC 12228 15.6
S. pneumoniae ATCC 6003 > 1000
S. pyogenes ATCC 19615 > 1000
L. monocytogenes ATCC 7644 > 1000
L. monocytogenes ATCC 1392 > 1000
E. hirae ATCC 10541 >1000
M. catarrhalis ATCC 8176 >1000
Values are expressed as μg ml-1 and represent the mean of three determinations.
3,4-DHPEA-EA: (methyl-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-formyl-2-
methyl-3,4-dihydro-2H-pyran-5-carboxylate).
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of MICs were obtained with the broth microdilution
method and in the Bioscreen C. No differences in the
MIC values were recorded with the two solvents utilized
(methanol or DMSO). Amongst the Gram-positive bac-
teria tested, 3,4-DHPEA-EA was active against staphylo-
cocci, the most sensitive strains being S. epidermidis
ATCC 49134 and S. epidermidis ATCC 12228, followed
by S. aureus spp. The effect was bacteriostatic rather than
bactericidal.
Table 2 reports the MICs of 3,4-DHPEA-EA against
the clinical and food isolates tested. MIC values of 7.8
and 15.6 μg ml-1 3,4-DHPEA-EA, respectively, inhibited
the growth of 50% and 90% of the S. epidermidis strains
tested, whereas 125 and 250 μg ml-1 3,4-DHPEA-EA,
respectively, inhibited the growth of 50% and 90% of
the S. aureus strains tested. All the other isolates wereTable 2 Minimum inhibitory concentration (MIC) of
3,4-DHPEA-EA against food and clinical isolates
Strain MIC 50 MIC 90
S. aureus 125 250
S. epidermidis 7.8 15.6
S. pyogenes > 1000 > 1000
S. pneumoniae > 1000 > 1000
M. catarrhalis > 1000 > 1000
L. monocytogenes > 1000 > 1000
E. faecalis > 1000 > 1000
E. fecium > 1000 > 1000
Values are expressed as μg ml-1 and represent the mean of three determinations.
3,4-DHPEA-EA: (methyl-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-formyl-2-
methyl-3,4-dihydro-2H-pyran-5-carboxylate).resistant. Higher MIC values were obtained with S. aureus
compared to S. epidermidis (Table 2).
Discussion
The present study has evaluated the antimicrobial effect
of a metabolite from oleuropein, 3,4-DHPEA-EA, against
a range of Gram-positive bacteria, which included ATCC
strains, food and clinical isolates. We have recently dem-
onstrated that polyphenols from pistachios had a bac-
tericidal effect against S. aureus and L. monocytogenes
[21], whereas almond skin extracts rich in polyphenols
were active against a range of Gram-positive bacteria
[22]. The effect on S. aureus could be used to find po-
tential applications as a topical treatment for S. aureus.
Other authors have reported on the antioxidant and
antimicrobial activities of individual and combined phe-
nolics in Olea europea leaf extract: oleuropein and caffeic
acid were active against Salmonella enteridis, Bacillus
cereus and Escherichia coli and the antimicrobial effect of
the combined phenolics was significantly higher than
those of the individual compounds [23]. Using agar dilu-
tion and broth microdilution techniques, Sudjana et al.
[24] found that a commercial olive leaf extract was ac-
tive against Campylobacter jejuni, Helicobacter pylori
and Staphylococcus aureus with low MIC concentra-
tions (0.31–0.78% v/v). Another investigation on the
antimicrobial effect of an olive leaf extract showed that
Bacillus subtilis was less susceptible than E. coli, Pseudo-
monas aeruginosa, Klebsiella pneumoniae and S. aureus
[25]. A commercial olive powder and 4-hydroxytyrosol
were able to inactivate S. aureus and its enterotoxin A,
secreted by the bacteria in 78% of the outbreaks [26]. Al-
though no reports have identified the possible mecha-
nisms of action of the phenolic compounds present in
olive leaf, some authors report the activity of phenolics on
Gram-positive bacteria may be due to the cell wall or cell
membrane disruption together with cell enlargement,
which is more susceptible compared to Gram-negative
strains [27]. Fabiani et al. [28] demonstrated that hydrogen
peroxidase production is responsible for the induction of
apoptosis by hydroxytyrosol on HL60 cells.
In our previous study we demonstrated that oleuro-
pein and hydroxytyrosol were active against ATCC
strains and clinical isolates: the MIC values of hydroxy-
tyrosol ranged between 0.24 and 7.85 μg ml-1 for ATCC
strains and between 0.97 and 31.25 μg ml-1 for clinically
isolated strains, whereas the MIC values of oleuropein
ranged between 62 and 500 μg ml-1 for ATCC strains
and between 31.25 and 250 μg ml-1 for clinically isolated
strains [3]. Although oleuropein was found effective
against a range of Gram-positive strains, in the present
work we demonstrated that 3,4-DHPEA-EA, a metabol-
ite obtained by hydrolysis of oleuropein, was only active
against ATCC and clinical isolates of S. aureus and
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fore be tested in combination with traditional antibiotics
in order to identify new mechanisms of synergism and
antibiotic-resistant modulating properties for the devel-
opment of novel drugs. On the basis of previous investi-
gations on the absorption and metabolism of olive oil
secoiridoids in the small intestine [29], further studies
need to be performed to elucidate the formation of 3,4-
DHPEA-EA in the stomach.
Conclusions
In summary, the results of the present study showed that a
metabolite from oleuropein was effective against staphylo-
cocci and could therefore be a potential source of natural
antimicrobials for the treatment of skin infections. How-
ever, further studies are needed to understand the mecha-
nisms responsible for these activities and the obtained
in vitro results need to be translated both in food and
in vivo.
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